Results 181 to 190 of about 184,353 (274)

Neurobiological correlates of obsessive‐compulsive disorder (OCD): A narrative review

Ibrain, Volume 12, Issue 1, Page 86-95, Spring 2026.
Obsessive‐compulsive disorder (OCD) is a common and disabling, as well as underdiagnosed, neuropsychiatric condition characterized by involuntary and unwanted obsessions and/or compulsions often accompanied by states of severe anxiety, distress and shame, as well as other comorbid disorders. Despite the extensive literature available to date, only some
Giulio Perrotta, Anna Sara Liberati
wiley   +1 more source

Subtypes of tic disorders in children and adolescents: based on clinical characteristics. [PDF]

BMC Pediatr
Yang K, Zhang W, Li Y, Wang X, Jiang Z, Hu S, Jun J, Yang Q, Li J, Hong X, Cui Y, Lei T.   +11 more
europepmc   +1 more source

Cross‐cultural variations in executive function impairments among children with attention deficit/hyperactivity disorder

JCPP Advances, Volume 6, Issue 1, March 2026.
This study explores the role of culture in executive function (EF) deficits in children with ADHD by comparing Chinese and Australian populations. Using rigorous methodologies such as propensity score matching and consistent diagnostic procedures, the research reveals distinct EF profiles, including a subgroup of Chinese children with severe EF ...
Da‐Wei Zhang, Ameera Shahira Amran, Yishu Qin, Han Jiang, Li Sun, Mark A. Bellgrove, Stuart J. Johnstone   +6 more
wiley   +1 more source

Clinical characteristics and pharmacotherapy choices in children newly diagnosed with tic disorders in China: a retrospective cohort study. [PDF]

BMJ Paediatr Open
Xiang Y, Tong C, Lu Q, Sun D, Liu Z.
europepmc   +1 more source

Evaluating the efficacy of psychological therapies for generalised anxiety disorder in children and adolescents: A systematic review and narrative synthesis

JCPP Advances, Volume 6, Issue 1, March 2026.
Abstract Background Generalised Anxiety Disorder (GAD) is common in children and adolescents, and if not successfully treated, has negative consequences for their current and subsequent mental health. Whilst psychological therapies have previously been assessed in terms of their efficacy for a combination of anxiety disorders, no existing systematic ...
Lottie Shipp, Eleanor Leigh, Sakshi Rajesh, Polly Waite   +3 more
wiley   +1 more source

Frequency of body focused repetitive behaviors and comparison to self-injurious behaviors in patients with tic disorders. [PDF]

Sci Rep
Szejko N, Schlarmann HG, Müller-Vahl KR.   +2 more
europepmc   +1 more source

Brain Age in Adult Patients With Early‐Treated Phenylketonuria

Journal of Inherited Metabolic Disease, Volume 49, Issue 2, March 2026.
ABSTRACT Structural brain alterations have been observed in individuals with phenylketonuria (PKU); however, the potential impact of PKU on brain aging remains unexplored. This study investigated brain age in adults with early‐treated classical PKU compared to healthy controls. Thirty early‐treated adults with classical PKU (age 19–48 years) and 59 age‐
Laura Winiger, Raphaela Muri, Tobias Kaufmann, Michel Hochuli, Emma Vardy, Piotr Radojewski, Katarzyna Pospieszny, Roman Trepp, Regula Everts   +8 more
wiley   +1 more source

Digitally enabled therapy for chronic tic disorders and Tourette Syndrome: a systematic review and economic evaluation.

Health Technol Assess
Boyers D, Cruickshank M, Azharuddin M, Manson P, Swallow D, Counsell C, Brazzelli M.   +6 more
europepmc   +1 more source

Effect of CYP2D6 and ABCB1 polymorphisms on pharmacokinetics and efficacy of aripiprazole in pediatric tic disorders. [PDF]

BMC Pediatr
Xin Y, Gao L, Li S, Wang J, Chen C, Tuo Y, Nie G, Li R, Sun D, Fu Y, Wang Y, Liu Z.   +11 more
europepmc   +1 more source

Pegvaliase Treatment for Adolescents With Phenylketonuria: A Multi‐Site Study

JIMD Reports, Volume 67, Issue 2, March 2026.
ABSTRACT Phenylketonuria (PKU) is an inherited metabolic disorder causing elevated phenylalanine (Phe) levels and neurocognitive impairment if left untreated. While dietary therapy remains the treatment standard, adherence declines during adolescence. Pegvaliase, an injectable enzyme therapy approved for adults > 18 years in the United States, lowers ...
Suzanne Hollander, Briana Valli, Erika Vucko, Melissa Lah, Amarilis Sanchez‐Valle, Brittany M. Murray, Amy Kritzer, Stephanie Sacharow   +7 more
wiley   +1 more source